The impact of general anesthesia on methionine metabolism during cardiopulmonary bypass

It has been found out that methylation of nucleic acids, proteins and low-molecular substrates is necessary to renew cellular structures, their restoration and cytoprotection. Methionine plays the most important role in this process but whether its metabolism changes during anesthesia and how different anesthetics affect it, has not yet been studied.

The objective: to study the metabolism of methionine during cardiopulmonary bypass when the direct myocardial revascularization is performed and the impact of the anesthetics used (propofol, desflurane, and sevoflurane) on methionine metabolism.

Subjects and methods: 74 patients who underwent surgery due to coronary heart disease with cardiopulmonary bypass were enrolled in the study. The patients were divided into three groups by the anesthetic used (desflurane, sevoflurane, propofol). Levels of methionine, homocysteine, cysteine, and taurine were tested in the blood collected from veins and jugular vein before the aorta clamping and after the release of clamps.

Results. In all three groups, lower levels of methionine and a higher level of homocysteine were observed after the release of clamps from the aorta, especially in the jugular vein. The most significant consumption of methionine was noted when propofol was used. In the same group, the exocytic release of homocysteine into the blood and the formation of cysteine were significantly lower. No significant difference was observed in the effect of desflurane and sevoflurane on methylation.

Conclusion. During the anoxia, the consumption of methionine increases significantly but the intensity of demethylation/remethylation depends on the anesthetics used during anesthesia. The most significant decrease in the level of methionine as well as the remethylation of homocysteine into methionine occurs with the use of propofol, rather than inhalation anesthetics which may be a consequence of desflurane and sevoflurane cytoprotective properties.

1. Zhloba A.A. Laboratory diagnosis in hyperhomocysteinemia. Kliniko-laboratorny Konsilium, 2009, vol. 26, no. 1, pp. 49-60. (In Russ.) https://www.1spbgmu.ru/images/home/universitet/izdatelstvo/Kliniko-lab_konsil/2009/klk1262009.pdf.

2. Zhloba А.А., Subbotina T.F., Molchan N.S., Polushin Yu.S. Homoarginine level and methionine-homocysteine balance in patients with ischemic heart disease. Klinicheskaya Laboratornaya Diagnostika, 2019, vol. 64, no. 9, pp. 516-524. (In Russ.) https://www.medlit.ru/journalsview/lab/view/journal/2019/issue-9/1881-uroven-gomoarginina-i-balans-metionin-gomocistein-u-pacientov-s-ishemicheskoy-bolezn-yu-serdca/

3. Molchan N.S., Polushin Yu.S., Zhloba А.А. et al. Impact of anesthesia with prolonged use of desflurane and sevoflurane on the cardiac function in coronary artery bypass graft surgeries with cardiopulmonary bypass. Messenger of Anesthesiology and Resuscitation, 2017, vol. 14, no. 4, pp. 23-31. (In Russ.) https://doi.org/10.21292/2078-5658-2017-14-4-23-31

4. Molchan N.S., Polushin Yu.S., Zhloba А.А. et al. Is it possible to augment myocardial protection during cardiopulmonary bypass by administration of inhalational anesthetics? Аlmanakh Klinicheskoy Meditsiny, 2019, vol. 47, no. 3, pp. 221-227. (In Russ.) https://doi.org/10.18786/2072-0505-2019-47-036.

5. Polushin А.Yu., Odinak M.M., Yanishevskiy S.N. et al. Hyperhomocysteinemia as predictor of stroke severity on background of extensive brain substance injury. Vestnik Rossiiskoy Voenno-Meditsinskoy Akademii, 2013, vol. 4, no. 4, pp. 89-94. (In Russ.)

6. Molchan N.S., Polushin Yu.S., Zhloba А.А. et al.. Pre-perfusion lactate level and lactate-pyruvate ratio as a prognostic criterion of development of post-perfusion cardiac failure during the myocardial revasculization surgery with the use of cardiopulmonary bypass. Messenger of Anesthesiology and Resuscitation, 2016, vol. 13, no. 4, pp. 19-28. (In Russ.) https://doi.org/10.21292/2078-5658-2016-13-4-19-28.

7. Alam A., Hana Z., Jin Z. et al. Surgery, neuroinflammation and cognitive impairment. E. BioMedicine. 2018, vol. 37, pp. 547-556. https://doi:10.1016/j.ebiom.2018.10.021.

8. Avidan M.S., Evers A.S. The fallacy of persistent postoperative cognitive decline. Anesthesiology, 2016, vol. 124, no. 2, pp. 255-258. https://doi:10.1097/ALN.0000000000000958.

9. Dash P.K., Hergenroeder G.W., Jeter C.B. et al. Traumatic brain injury alters methionine metabolism: implications for pathophysiology. Front. Syst. Neurosci., 2016, vol. 10, pp. 36. https://doi:10.3389/fnsys.2016.00036.

10. Dokkedal U., Hansen T.G., Rasmussen L.S. et al. Cognitive functioning after surgery in middle-aged and elderly danish twins. Anesthesiology, 2016, vol. 124, no. 2, pp. 312-321. https://doi:10.1097/ALN.0000000000000957.

11. Ekdahl C.T., Claasen J.H., Bonde S. et al. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA, 2003, vol. 11, no. 23, pp. 13632-13637. https://doi:10.1073/pnas.2234031100.

12. Gao J., Cahill C.M., Huang X. et al. S-Adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life. Neurotherapeutics, 2018, vol. 15, no. 1, pp. 156-175. https://doi:10.1007/s13311-017-0593-0.

13. Goulart V.A.M., Sena M.M., Mendes T.O. et al. Amino acid biosignature in plasma among ischemic stroke subtypes. BioMed. Res. Int., 2019, Article ID 8480468. https://doi.org/10.1155/2019/8480468.

14. Kabil O., Motl N., Banerjee R. H2S and its role in redox signaling. Biochim. Biophys. Acta., 2014, vol. 1844, no. 8, pp. 1355-1366. https://doi:10.1016/j.bbapap.2014.01.002.

15. Karas K.N. S-Adenosyl Methionine in the therapy of depression and other psychiatric disorders. Drug Dev. Res., 2016, vol. 77, no. 7, pp. 346‒356. https://doi:10.1002/ddr.21345.

16. Miller D., Lewis S.R., Pritchard M.W. et al. Intravenous versus inhalational maintenance of anaesthesia for postoperative cognitive outcomes in elderly people undergoing non-cardiac surgery. Cochrane Database Syst. Rev., 2018, vol. 8, CD012317. https://doi:10.1002/14651858.CD012317.pub2.

17. Moller J.T., Cluitmans P., Rasmussen L.S. et al. Long term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International study of post-operative cognitive dysfunction. Lancet, 1998, vol. 21, no. 351 (9106), pp. 857-861. https://doi:10.1016/s0140-6736(97)07382-0.

18. Monk T.G, Weldon B.C., Garvan C.W. et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology, 2008, vol. 108, no. 1, pp. 18-30. https://doi:10.1097/01.anes.0000296071.19434.1e.

19. Moretti R., Caruso P. The controversial role of homocysteine in neurology: from labs to clinical practice. Int. J. Mol. Sci., 2019, vol. 20, no. 1, pp. 231. https://doi:10.3390/ijms20010231.

20. Olotu C. Postoperative neurocognitive disorders. Curr. Opin. Anaesthesiol., 2020, vol. 33, no. 1, pp. 101-108. https://doi:10.1097/ACO.0000000000000812.

21. Schraag S., Pradelli L., Alsaleh A.J.O. et al. Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis. BMC Anesthesiol., 2018, vol. 18, no. 1, pp. 162. https://doi:10.1186/s12871-018-0632-3.

22. Vizcaychipi M.P. Post-оperative сognitive dysfunction: рre-оperative risk assessment and peri-operative risk minimization: а pragmatic review of the literature. J. Intens. Crit. Care, 2016, vol. 2, no. 2, pp. 13. https://doi:10.1007/s11695-017-2929-6.

23. Xiao Y., Su X., Huang W et al. Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism. Int. J. Biochem. Cell Biol., 2015, vol. 67, pp. 158–166. https://doi:10.1016/j.biocel.2015.06.015.

24. Yi P., Melnyk S., Pogribna M. et al. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem., 2000, vol. 275, no. 38, pp. 29318-29323. https://doi:10.1074/jbc.M002725200.